Dabur arm ties up with Abbott Lab

NEW DELHI: Dabur Oncology plc, a U.K.-based subsidiary of Dabur India, on Wednesday announced a strategic alliance with the U.S. pharma major Abbott Laboratories for marketing generic oncology products in the U.S. Under the terms of agreement, Dabur will provide Abbott with products in finished dosage form, and Abbott will market the products in the U.S. A joint management committee comprising members from both companies will be formed to manage the alliance.


Recommended for you